詳細

SNO 2020

カンファレンスのハイライトを確認する

Novel treatment has promising effects on quality of life for patients with Parkinson’s disease

Phase II study results suggest that treatment with the drug-device combination ND0612 may have a positive impact on patient-rated activities of daily living and quality of life in Parkinson’s disease (PD).

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.